Abstract
The present invention provides new solid state forms of L-Arginine, (3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopent[b]indole-3-acetate represented by the following structural formula-1a and processes for preparation thereof.
The present invention also provides various processes for the preparation of amorphous form of L-Arginine, (3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopent[b]indole-3-acetate.
The present invention further provides pharmaceutical compositions comprising solid state forms of compound of formula-1a.
Formula-1a
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Kammari Bal Raju, Garai Abhijit, Edulakanti Jhansi, MSN Laboratories Private Limited, R&D Center, Hyderabad, India., "Solid state forms of L-Arginine, (3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4 tetrahydro cyclopent[b]indole-3-acetate and processes for preparation thereof", Technical Disclosure Commons, (April 03, 2025)
https://www.tdcommons.org/dpubs_series/7968